Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Preservation of immune response during chemotherapy regimens

Preservation of immune response during chemotherapy regimens

US Patent 11529352 · Granted Dec 20, 2022

Estimated economic value: $6,084,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Morphic forms of trilaciclib and methods of manufacture thereof2025
Morphic forms of trilaciclib and methods of manufacture thereof2025
Antibodies that bind TNFRSF252025
G1T38 superior dosage regimes2025
Antibodies that bind TNFRSF252025
Substituted 1′,2′-dihydro-3′H-spiro[cyclohexane-1,4′-pyrimido[5′,4′:4,5]pyrrolo[2025
Treatment of Rb-negative tumors using topoisomerase inhibitors in combination wi2025
Treatment of Rb-negative tumors using topoisomerase inhibitors in combination wi2025
Treatment of Rb-negative tumors using topoisomerase inhibitors in combination wi2025
Morphic forms of trilaciclib and methods of manufacture thereof2024
Transient protection of normal cells during chemotherapy2023
Transient protection of normal cells during chemotherapy2023